IN VITRO METABOLISM OF THE CALMODULIN ANTAGONIST DY-9760e (3-[2-[4-(3-CHLORO-2-METHYLPHENYL)-1-PIPERAZINYL]ETHYL]-5,6-DIMETHOXY-1-(4-IMIDAZOLYLMETHYL)-1H-INDAZOLE DIHYDROCHLORIDE 3.5 HYDRATE) BY HUMAN LIVER MICROSOMES: INVOLVEMENT OF CYTOCHROMES P450 IN ATYPICAL KINETICS AND POTENTIAL DRUG INTERACTIONSShuko Tachibana, Kenichi Sudo, Osamu Okazaki et al.|Drug Metabolism and Disposition|2005Cited by 8
Metabolism of the calmodulin antagonist DY-9760e in animals and humansShuko Tachibana, Kenichi Sudo, Wataru Suzuki et al.|Xenobiotica|2005Cited by 5
Pharmacokinetics and Disposition of DY-9760e, a Novel Calmodulin Antagonist, in Rats and MonkeysShuko Tachibana, Kenichi Sudo, Yuko Fujimaki et al.|Arzneimittelforschung|2011Cited by 4
Determination of a novel calmodulin antagonist, 3-{2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl}-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate, DY-9760e, in human plasma using solid-phase extraction and high-performance liquid chromatography with fluorescence detectionShuko Tachibana, Μakoto Tanaka, Kenichi Sudo et al.|Journal of Chromatography B Biomedical Sciences and Applications|1999Cited by 4